Why Tesla Stock Popped Today
Investors may soon have another reason to buy the EV leader’s shares.
Mindfully Curated
Investors may soon have another reason to buy the EV leader’s shares.
Glia affected by Huntington’s disease respond by tuning down synapse genes, which has a protective effect.
Prior research shows 98 percent of employees experience rude behavior at work, but that statistic may be misunderstood, according to new study.
During the continued progression of the coronavirus pandemic, rapid, inexpensive, and reliable tests will become increasingly important to determine whether people have the associated antibodies — either through infection or vaccination. Researchers h…
Measuring ethane in the atmosphere shows that the amounts of methane going into the atmosphere from oil and gas wells and contributing to greenhouse warming is higher than suggested by the U.S. Environmental Protection Agency, according to an internati…
In a large study of Chinese cats, genetic detectives highlight the evolutionary uniqueness and premier conservation importance of the elusive Chinese mountain cat (Felis silvestris bieti), found only in the Tibetan plateau of China.
Adolescent marijuana use and binge drinking did not significantly change during the COVID-19 pandemic, despite record decreases in the substances’ perceived availability, according to a survey of 12th graders in the United States. The study’s findings …
You’ll never believe whom these companies have to thank for their big gains.
WOR earnings call for the period ending May 31, 2021.
Not every day can see massive gains for the theater operator.
After China’s crackdown on Bitcoin, a major financial institution is bearish on the cryptocurrency.
Enough consumers like the option, but most consumers don’t seem to love it as much as some retailers were hoping.
ACN earnings call for the period ending May 31, 2021.
Investors are breathing easier after the FDA’s response to a potential link between Moderna’s vaccine and heart inflammation issues.
Investors appear to be changing their minds about this rising tech star.
The rise of meme stocks continues, and analysts are now also chiming in.
Investors don’t like the company’s first-quarter update.
This seems to be a continuation of volatility resulting from fears of inflation.
A lot of promising debutantes have hit the market over the past year. Let’s go over some of the better ones that are now on sale.
Investors expecting Gilead Sciences to license Arcus Biosciences’ lead asset could be in for an unpleasant surprise.